Isotretinoin and the risk of erythema multiforme Final SPC and PL wording agreed by the PhVWP in June 2010 Doc. Ref.: CMDh PhVWP[removed]Rev 1 July 2010 SUMMARY OF PRODUCT CHARACTERISTICS Section 4.4 - Stevens–Johnson syndrome - Document - PDFSEARCH.IO

First Page	Meta Content
	Isotretinoin and the risk of erythema multiforme Final SPC and PL wording agreed by the PhVWP in June 2010 Doc. Ref.: CMDh/PhVWP[removed]Rev 1 July 2010 SUMMARY OF PRODUCT CHARACTERISTICS Section 4.4 Add to Reading List Document Date: 2010-08-05 07:05:26 Open Document File Size: 67,65 KB Share Result on Facebook MedicalCondition fever / paronychia / Stevens-Johnson syndrome / e.g. erythema multiforme / conjunctivitis / erythema multiforme July / Acne / Erythema multiforme / exanthema / headache / Cheilitis / Skin disorders / hirsutism / infection / subcutaneous tissues disorders / central blisters / dermatitis / pyogenic granuloma / Stevens- Johnson syndrome / erythema multiforme Final SPC / pruritus / hair disorders / rash / skin hyperpigmentation / body aches / toxic epidermal necrolysis / erythema / / SocialTag Dermatology Erythema multiforme Toxic epidermal necrolysis Isotretinoin Stevens–Johnson syndrome Erythema Rash Erythema multiforme major Medicine Drug eruptions

Isotretinoin and the risk of erythema multiforme Final SPC and PL wording agreed by the PhVWP in June 2010 Doc. Ref.: CMDh/PhVWP[removed]Rev 1 July 2010 SUMMARY OF PRODUCT CHARACTERISTICS Section 4.4Add to Reading List